Calabrese Mary MD - Boston, Massachusetts 02125

Calabrese Mary MD is categorized under Doctors in Boston, MA .

Business Name: Calabrese Mary MD
Contact Person: Mary Calabrese
Address: 1280 Massachusetts Avenue, Boston, Massachusetts 02125
Phone Number: (617) 598-0574
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Suny Geneseo - Boston, MA 02125
Krueger John P P MD - Boston, MA 02125
Benyas Steven MD - Boston, MA 02125
Galvez-Buccoll Juan MD - Boston, MA 02125
DE Moya Adriana G MD - Boston, MA 02125
Moths-Rebrovic Elisabeth J MD - Boston, MA 02125
Henricks Elise M MD - Boston, MA 02125
Farrell-Riley Christine A MD - Boston, MA 02125
Columbia Medical Group - Boston, MA 02125
Fuller Jon D MD - Boston, MA 02125
Colby Linda M MD - Boston, MA 02125
Sanders Valerie E MD - Boston, MA 02125
Liana Buccieri Licsw - Boston, MA 02125
Chang Laura K MD - Boston, MA 02125
Uphams Corner Health Committee Inc - Boston, MA 02125
Tahmassian Ani MD - Boston, MA 02125
Ambewadikar Samrat V MD - Boston, MA 02125
Bird Jr Richard C MD - Boston, MA 02125
Gustafson Paul B MD - Boston, MA 02125
Viola Jessica MD - Boston, MA 02125

The company Calabrese Mary MD provides B2C services in the form of Doctors from its single location in Massachusetts. 1 to 4 employees work for Calabrese Mary MD, and the business now earns $500.000 to $999.999 per annum.

Calabrese Mary MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Calabrese Mary MD, please call Mary Calabrese with the phone number (617) 598-0574 or visit its single location at 1280 Massachusetts Avenue in Boston, Massachusetts 02125.

The location of the single location can also be found using the coordinates 42.321033,-71.062188. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.